Sign up to save your podcasts
Or
Share Antineoplastic Agents in Breast Cancers With Mutational Signatures
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Antineoplastic Agents in Breast Cancers With Mutational Signatures
Dr Markman encourages review of recently reported possible effect of ovarian cancer antineoplastic agents in breast cancer patients with rare BRCA mutational signatures.
View all episodes
By MedscapeDr Markman encourages review of recently reported possible effect of ovarian cancer antineoplastic agents in breast cancer patients with rare BRCA mutational signatures.